EXHIBIT 99.6
                                  PR NEWSWIRE INVESTORFAX
 
     Ophthalmic Imaging Systems Announces Delisting by Boston Stock Exchange

     SACRAMENTO, Calif., March 6 /PRNewswire/ -- Ophthalmic Imaging Systems
(Nasdaq: OISI) announced today that the Boston Stock Exchange has made the
decision to suspend the Company's common stock from trading as of the close of
business on March 3, 1998 and is filing for delisting with the Securities and
Exchange Commission. In addition, Nasdaq has indicated that it intends to delist
the Company's stock, and a decision is expected next week as to whether such
delisting will take place prior to the closing of the exchange offer previously
announced by Premier Laser Systems, Inc. and OIS.

     The decision of the Boston Stock Exchange, and the potential decision of
Nasdaq, shall not affect Premier Laser Systems' previously announced decision to
commence a tender offer to OIS shareholders. Premier intends to offer, in return
for each share of OIS tendered, $1.75 in cash, $0.25 in Premier stock and two
warrants, each of which permit the holder to acquire $0.25 worth of stock for a
nominal purchase price if OIS meets certain future revenue goals. Premier's
tender offer for OIS' stock will commence promptly following the effectiveness
of Premier's related registration statement.

     The completion of the tender offer is subject to customary conditions,
including registration with the Securities and Exchange Commission of the
securities to be offered to the OIS shareholders.

     Premier Laser Systems develops, manufactures and markets several lines of
proprietary medical lasers, fiber optic delivery systems, corneal topography
systems and associated products and services for a variety of dental, ophthalmic
and surgical applications.

     Ophthalmic Imaging Systems is the leading provider of ophthalmic digital
imaging systems. The Company designs, develops, manufactures, and markets
digital imaging and image enhancement systems and analysis software. With over a
decade in the ophthalmic imaging business, OIS has consistently been the first
to introduce new technology and features. The Company offers customer support
through a worldwide network of service technicians. The Company is currently
leveraging its digital imaging technology and established customer base to
develop products features and services targeting telemedicine/managed care
applications for the ocular health care industry.

     NOTE: This press release contains forward looking statements that are
subject to risks and uncertainties that could cause actual results to differ
materially from those set forth in the forward looking statements. These forward
looking statements represent Ophthalmic Imaging Systems' judgment as of the
date of this release. OIS disclaims any intent or obligation to update these
forward-looking statements.


SOURCE  Ophthalmic Imaging Systems
CONTACT: Jack Bothe of JR Bothe & Associates, 800-261-8552, for Ophthalmic
Imaging Systems
(OISI)